Divestment
Nektar Therapeutics Sells Alabama Manufacturing Facility and Reagent Business for $90 Million
Nektar Therapeutics, manufacturing site, reagent arm, divestment, Ampersand, $90 million
EU Approves Illumina’s Divestment Plan for Cancer Test Maker Grail
Illumina, Grail, EU clearance, Divestment, European Commission, Cancer diagnostic subsidiary, Capitalization terms
European Commission Grants Approval for Illumina to Divest Grail
Illumina, Grail, European Commission, Divestment, Competition, Antitrust